AR023562A1 - Derivado de tiazolidin-2,4-diona, una composicion farmaceutica que los comprende, y el uso del mismo para la fabricacion del medicamento - Google Patents

Derivado de tiazolidin-2,4-diona, una composicion farmaceutica que los comprende, y el uso del mismo para la fabricacion del medicamento

Info

Publication number
AR023562A1
AR023562A1 ARP000101863A ARP000101863A AR023562A1 AR 023562 A1 AR023562 A1 AR 023562A1 AR P000101863 A ARP000101863 A AR P000101863A AR P000101863 A ARP000101863 A AR P000101863A AR 023562 A1 AR023562 A1 AR 023562A1
Authority
AR
Argentina
Prior art keywords
pharmaceutical composition
tiazolidin
diona
understands
derived
Prior art date
Application number
ARP000101863A
Other languages
English (en)
Spanish (es)
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of AR023562A1 publication Critical patent/AR023562A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
ARP000101863A 1999-04-20 2000-04-19 Derivado de tiazolidin-2,4-diona, una composicion farmaceutica que los comprende, y el uso del mismo para la fabricacion del medicamento AR023562A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9909041.7A GB9909041D0 (en) 1999-04-20 1999-04-20 Novel pharmaceutical

Publications (1)

Publication Number Publication Date
AR023562A1 true AR023562A1 (es) 2002-09-04

Family

ID=10851901

Family Applications (2)

Application Number Title Priority Date Filing Date
ARP000101863A AR023562A1 (es) 1999-04-20 2000-04-19 Derivado de tiazolidin-2,4-diona, una composicion farmaceutica que los comprende, y el uso del mismo para la fabricacion del medicamento
ARP000101868A AR023566A1 (es) 1999-04-20 2000-04-19 Un procedimiento para el dihidrato del hidrocloruro derivado de la tiazolidina-2,4-diona

Family Applications After (1)

Application Number Title Priority Date Filing Date
ARP000101868A AR023566A1 (es) 1999-04-20 2000-04-19 Un procedimiento para el dihidrato del hidrocloruro derivado de la tiazolidina-2,4-diona

Country Status (42)

Country Link
EP (2) EP1173436B1 (enExample)
JP (2) JP4283449B2 (enExample)
KR (1) KR100601244B1 (enExample)
CN (2) CN1327447A (enExample)
AP (1) AP1562A (enExample)
AR (2) AR023562A1 (enExample)
AT (1) ATE268770T1 (enExample)
AU (2) AU4130900A (enExample)
BG (1) BG65864B1 (enExample)
BR (1) BR0009897A (enExample)
CA (1) CA2382036A1 (enExample)
CO (1) CO5170422A1 (enExample)
CZ (1) CZ300653B6 (enExample)
DE (1) DE60011419T2 (enExample)
DK (1) DK1173436T3 (enExample)
DZ (1) DZ3162A1 (enExample)
EA (1) EA004232B1 (enExample)
EG (1) EG24063A (enExample)
ES (1) ES2218146T3 (enExample)
GB (1) GB9909041D0 (enExample)
HK (1) HK1045151B (enExample)
HR (1) HRP20010770B1 (enExample)
HU (1) HUP0200865A3 (enExample)
IL (1) IL146078A0 (enExample)
MA (1) MA26783A1 (enExample)
MX (1) MXPA01010696A (enExample)
MY (1) MY126034A (enExample)
NO (1) NO320609B1 (enExample)
NZ (1) NZ515166A (enExample)
OA (1) OA11866A (enExample)
PE (1) PE20010050A1 (enExample)
PL (1) PL351135A1 (enExample)
PT (1) PT1173436E (enExample)
RS (1) RS50136B (enExample)
SI (1) SI1173436T1 (enExample)
SK (1) SK284991B6 (enExample)
TR (1) TR200103040T2 (enExample)
TW (1) TWI277616B (enExample)
UA (1) UA71615C2 (enExample)
UY (1) UY26112A1 (enExample)
WO (1) WO2000063205A2 (enExample)
ZA (1) ZA200108720B (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9909041D0 (en) * 1999-04-20 1999-06-16 Smithkline Beecham Plc Novel pharmaceutical
GB0006133D0 (en) 2000-03-14 2000-05-03 Smithkline Beecham Plc Novel pharmaceutical
GB0014005D0 (en) * 2000-06-08 2000-08-02 Smithkline Beecham Plc Novel pharmaceutical
SI1448559T1 (sl) * 2001-11-21 2007-06-30 Smithkline Beecham Plc 5-(4-(2-(n-metil-n-(2-piridil)amino)etoksi)benzil-tiazolidin-2,4-dion- benzensulfonat; postopek za njegovo pripravo; njegovi polimorfi i, ii, iii; in njegova uporaba kot farmacevtska uäśinkovina
GB0129872D0 (en) * 2001-12-13 2002-02-06 Smithkline Beecham Plc Novel pharmaceutical
CZ296468B6 (cs) * 2004-06-10 2006-03-15 Zentiva, A. S. Sul kyseliny fosforecné s 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidin-2,4-dionema zpusob její prípravy
CZ296472B6 (cs) * 2004-07-27 2006-03-15 Zentiva, A. S Sul kyseliny stavelové s 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidin-2,4-dionu azpusob její prípravy a její pouzití
CZ298424B6 (cs) * 2005-05-24 2007-09-26 Zentiva, A. S. Zpusob krystalizace rosiglitazonu a jeho derivátuze smesných rozpouštedel
EP1842850A1 (en) * 2006-03-23 2007-10-10 Sandoz AG Rosiglitazone hydrochloride hemihydrate

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0842925A1 (en) * 1987-09-04 1998-05-20 Beecham Group Plc Substituted thiazolidinedione derivatives
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
GB9726563D0 (en) * 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
GB9726568D0 (en) * 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
GB9726566D0 (en) * 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
GB9909041D0 (en) * 1999-04-20 1999-06-16 Smithkline Beecham Plc Novel pharmaceutical

Also Published As

Publication number Publication date
RS50136B (sr) 2009-03-25
MXPA01010696A (es) 2002-06-04
SK14902001A3 (sk) 2002-02-05
YU81501A (sh) 2004-07-15
SK284991B6 (sk) 2006-04-06
DE60011419D1 (de) 2004-07-15
HUP0200865A2 (en) 2002-08-28
IL146078A0 (en) 2002-07-25
MY126034A (en) 2006-09-29
EP1411055A1 (en) 2004-04-21
AU2755202A (en) 2002-05-16
ZA200108720B (en) 2002-11-28
MA26783A1 (fr) 2004-12-20
KR20010110791A (ko) 2001-12-13
PT1173436E (pt) 2004-10-29
ATE268770T1 (de) 2004-06-15
EP1173436A2 (en) 2002-01-23
PL351135A1 (en) 2003-03-24
NO20015104L (no) 2001-12-19
SI1173436T1 (en) 2004-12-31
WO2000063205A3 (en) 2001-01-25
HK1045151B (en) 2005-03-18
UA71615C2 (uk) 2004-12-15
TR200103040T2 (tr) 2002-04-22
HRP20010770A2 (en) 2002-10-31
AU4130900A (en) 2000-11-02
CZ300653B6 (cs) 2009-07-08
EG24063A (en) 2008-05-08
AU765911B2 (en) 2003-10-02
KR100601244B1 (ko) 2006-07-19
OA11866A (en) 2006-03-02
WO2000063205A2 (en) 2000-10-26
DK1173436T3 (da) 2004-09-27
EA004232B1 (ru) 2004-02-26
UY26112A1 (es) 2000-12-29
HRP20010770B1 (en) 2005-06-30
HK1045151A1 (en) 2002-11-15
NZ515166A (en) 2004-02-27
PE20010050A1 (es) 2001-03-10
GB9909041D0 (en) 1999-06-16
JP2009143954A (ja) 2009-07-02
JP4283449B2 (ja) 2009-06-24
EP1173436B1 (en) 2004-06-09
BG106112A (bg) 2002-05-31
CZ20013759A3 (cs) 2002-05-15
EA200101101A1 (ru) 2002-04-25
CN101134756A (zh) 2008-03-05
AR023566A1 (es) 2002-09-04
DE60011419T2 (de) 2005-06-16
NO20015104D0 (no) 2001-10-19
BR0009897A (pt) 2002-04-16
CA2382036A1 (en) 2000-10-26
TWI277616B (en) 2007-04-01
DZ3162A1 (fr) 2000-10-26
BG65864B1 (bg) 2010-03-31
AP1562A (en) 2006-02-01
ES2218146T3 (es) 2004-11-16
HUP0200865A3 (en) 2005-04-28
CO5170422A1 (es) 2002-06-27
AP2001002331A0 (en) 2000-04-19
JP2002542242A (ja) 2002-12-10
CN1327447A (zh) 2001-12-19
NO320609B1 (no) 2005-12-27

Similar Documents

Publication Publication Date Title
AR066982A2 (es) Compuestos heteroaromaticos sustituidos como inhibidoress tirosin quinasa, composiciones farmaceuticas que los contiene y su uso en la preparacion de medicamentos
AR011759A1 (es) Compuesto derivado de fenoximetilpiperidina, procedimientos para su preparacion, una composicion farmaceutica, el uso del mismo para la preparacion de un medicamento, para la preparacion de un producto intermedio, un solvato y un envase
RU93043528A (ru) Моногидрат 5-(2-(4-(1,2-бензотиазол-3-ил)-1-пиперазинил)этил)-6-хлор-1,3-дигидро-2н-индол-2-он хлоргидрата, способ его получения, фармацевтическая композиция, способ лечения
ATE144503T1 (de) Thiazolidin-2,4-dionderivate, verfahren zu deren herstellung und sie enthaltende pharmazeutische zusammensetzungen
ATE122668T1 (de) Diarylsubstituierte heterocyclische verbindung, ihre herstellung und arzneimittel und kosmetika daraus.
AR023562A1 (es) Derivado de tiazolidin-2,4-diona, una composicion farmaceutica que los comprende, y el uso del mismo para la fabricacion del medicamento
AR023561A1 (es) Una forma polimorfica del acido maleico de un derivado de tiazolidin-2, 4 diona, una composicion farmaceutica y el uso de dicho polimorfo para lafabricacion de un medicamento
UY26120A1 (es) Nuevo compuesto farmacéutico art 127 de la ley 17164
GB0109122D0 (en) Novel compounds
SE9702305D0 (sv) New thiazolidinedione, oxazolidinedione and oxadiazolidinedione derivatives
DE59909606D1 (de) Substituierte 1,3-diaryl-2-pyridin-2-yl-3-(pyridin-2-ylamino)-propanolderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
AR023563A1 (es) Monohidrato de hidrocloruro de un derivado de tiazolidin-2,4-diona, una composicion farmaceutica y el uso del mismo para la fabricacion de un medicamento
DE69422532D1 (de) 2-[4-(4-Azolylbutyl)-1-piperazinyl]-5-hydroxypyrimidin-Derivate, deren Herstellung und deren Verwendung als Heilmittel
DE68901859D1 (de) 2-benzothiazolamin-derivate enthaltende arzneimittel, verbindungen und ihre herstellung.
ECSP034469A (es) Compuesto farmaceutico novedoso
CY1107252T1 (el) Τρυγικο αλας παραγωγου της θειζολιδινοδιονης
CY1105354T1 (el) Ένα παραγωγο θειαζολιδινοδιονης και η χρηση του σαν αντι-διαβητικο
ECSP003434A (es) Nuevos compuestos
CY1105903T1 (el) Ενα παραγωγο της θειαζολιδενεδιονης και η χρηση του σαν αντιδιαβητικο
ATE300530T1 (de) Azol- oder triazol-derivate, verfahren zu deren herstellung und ihre verwendung als antifungale arzneimittel
ECSP034466A (es) Farmaceutico novedoso
AP2002002684A0 (en) 5-(4-(2-(n-methyl-n-(2- pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione hydriodide as pharmaceutical.5-(4-(2-(n-methyl-n-(2- pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione hydriodide as pharmaceutical.5-(4-(2-(n-methyl-n-(2- pyridyl) amino)ethoxy) benzyl) thiazolidine-2, 4-dione hydriodide as pharmaceutical.5-(4-(2-(n-methyl-n-(2-pyridyl) amino) ethoxy)benzyl) thiazolidine-2,4-dione hydriodide as pharmaceutical
DE69117853D1 (de) Topisch anzuwendendes pulverförmiges Arzneimittel, das zyklische AMP-Derivate enthält
ECSP003438A (es) Nuevos compuestos
AR017867A1 (es) Un hidrato de la sal del acido maleico de 5-4-2-(n-metil-n(2-piridil)amino)etoxi bencil tiazolidin-2,4-diona, un proceso para su preparacion, una composicion farmaceutica que lo comprende y el uso del mismo para la fabricacion de un medicamento.

Legal Events

Date Code Title Description
FA Abandonment or withdrawal
FG Grant, registration